10 results
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... #Drugs
COVID-19 Diagnosis and Management Summary
Clinical and laboratory testing
Lung Ultrasound
HRCT scan
In-hospital treatment
Severity assessment and respiratory support 
Post-mortem
COVID-19 Diagnosis ... and Management ... Summary Clinical ... laboratory testing Lung ... Ultrasound HRCT
COVID-19 POCUS

96 yrs old, discharged 3 wks ago for CAP, treated with amox/clav then cefixime. Returns
Returns for dyspnea ... But this ultrasound ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
COVID-19 on POCUS

I am infected with COVID-19. This is my own #POCUS 2 days after the
COVID-19 on POCUS ... No feeling of dyspnea ... #POCUS #Clinical ... #Lung #Ultrasound ... #SARSCoV2 #Coronavirus
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
association with CTD, drugs ... Organizing Pneumonia - Clinical ... History: cough, dyspnea ... Organizing Pneumonia Treatment ... ILD #diagnosis #management
Myasthenic Crisis Checklist - Myasthenia Gravis

Evaluation 
 - Chest X-ray and lung ultrasound (exclude other lung
Chest X-ray and lung ... ultrasound (exclude ... appearance, subjective dyspnea ... Drugs to avoid ( ... MyastheniaGravis #Checklist #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... hemoptysis • Dyspnea ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... hemoptysis • Dyspnea ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
effects in the treatment ... • Therapeutic drug ... tolerable • Limited clinical ... fever, chills, dyspnea ... #valleyfever #management
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... Weaknesses: Therapeutic drug ... Weaknesses: Limited clinical ... fever, chills, dyspnea ... #pharmacology #management